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DISPATCHES

Human
Herpesvirus 8
Seroprevalence,
China
Tiejun Zhang, Xiaodan Shao, Yue Chen,
Tao Zhang, Veenu Minhas, Charles Wood,
and Na He
To summarize the seroprevalence of human herpesvirus 8 (HHV-8) in mainland China, we conducted a systematic review and meta-analysis based on available literature.
Data show that differences in HHV-8 prevalence vary considerably among different ethnic groups and geographic regions. Blood-borne transmission could be a potential route
for HHV-8 infection in China.

H

uman herpesvirus 8 (HHV-8) is the infectious etiologic agent associated with Kaposi sarcoma, primary
effusion lymphoma, and multicentric Castleman disease.
Worldwide seroprevalence of HHV-8 varies: generally
low to moderate for populations in Western countries and
Asia (1–4) but as high as 50% for the general population
in sub-Saharan Africa and higher for HIV-positive populations (5–7). The transmission modes of HHV-8 may also
differ in different geographic areas and subpopulations;
sexual and nonsexual transmission have been described
(8–10). Blood-borne transmission may exist, especially
among intravenous drug users (IVDUs) and blood recipients (11).
The Ministry of Health of China, the United Nations
Program on HIV/AIDS, and the World Health Organization estimate that ≈320,000 HIV/AIDS cases have been
reported in China (12). However, the epidemiologic characteristics of HHV-8 infection, a severe HIV/AIDS opportunistic infection, have not been well described for China.
Therefore, we conducted a systematic review and metaanalysis on the basis of available data for HHV-8 epidemiology from mainland China to have a better understanding
of the prevalence, variation, and factors associated with its
transmission.
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The Study
A comprehensive literature search of published studies indexed in global and databases in China during 1995–
2010 was conducted. Initially, 125 reports published in
English and 223 in Chinese concerning the seroprevalence in mainland China were identified. Among them, 85
articles published in England and 178 articles published
in China were excluded after title and abstract screening.
After reading the full text, we excluded another 33 English and 26 Chinese articles. Finally, 26 publications were
included in this systematic review and have been summarized in online Technical Appendix Table 1 (wwwnc.cdc.
gov/EID/pdfs/10-2070-Techapp.pdf). These studies were
cross-sectional and were conducted in 8 of the 34 provinces. A substantial number (35.5%) of these studies were
conducted in the Xinjiang Uygur Autonomous Region.
Most samples tested were serum or plasma with few exceptions (1 whole blood, 1 peripheral blood mononuclear
cells); sample sizes ranged from 37 to 4,461 (median 242,
interquartile range 199–520). Overall, 18,547 participants
were involved in the present analysis, and among them
15,913 were from the general population, 1,970 were immunocompromised patients, and 664 were IVDUs. Laboratory methods for all included studies were reported (19
detected HHV-8 by ELISA, 3 by PCR, and 4 by immunofluorescent assay.
The prevalence of HHV-8 pooled from reviewed studies was 11.3% (95% CI 7.2–15.5) for the general population, 22.2% (95% CI 12.7–31.8) for immunocompromised
patients, and 31.2% (95% CI 27.7–34.7) for IVDUs. The
prevalence among the general population was found to
be the lowest in Guangdong Province and the highest in
Xinjiang Province. A similar regional variation was found
for immunocompromised persons. Among IVDUs, the
prevalence was 34.3% (95% CI 28.3–40.3) in Zhejiang and
29.6% (95% CI 25.3–33.9) in Xinjiang Uygur Autonomous
Region (online Technical Appendix Table 2; Figure).
Five studies, including 4,637 persons of Han ethnicity and 4,011 persons of ethnic minorities (2,040 Uygur,
1,169 Kazak, 200 Khalkas, 173 Hue, and 429 other)
conducted in the Xinjiang Uygur Autonomous Region
were analyzed for association of ethnicity with HHV-8
prevalence (online Technical Appendix Figure, panel A).
The risk was significantly lower for the Han group than
for other ethnic groups (odds ratio [OR] = 0.59, 95% CI
0.55–0.76). For the Han group, the pooled prevalence of
HHV-8 in Xinjiang Uygur Autonomous Region was significantly higher when compared with that for other regions, 14.4% (95% CI 9.0–19.8) versus 6.4% (95% CI
4.1–8.6). Ten combined studies, with 5,716 male and
4,708 female participants, respectively, were included
in meta-analysis of association between sex and HHV8 infection (online Technical Appendix Figure, panel B).
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There was no significant difference between the sexes:
pooled OR 0.94 (95% CI 0.84–1.04).
Seven studies, with 863 HIV-positive patients and
3,438 negative controls, were included in the analysis. All
studies yielded a significant difference in HHV-8 infection
between HIV-positive and HIV-negative participants; ORs
for individual studies ranged from 1.50 to 4.27, and the
pooled OR was 2.97 (95% CI 2.22–3.97) (online Technical
Appendix Figure, panel C). However, a significant publication bias was detected (Egger test p = 0.013; Begg test p =
0.016). A visual inspection of the funnel plot suggested that
some large or small studies with negative or null results
were not published (data not shown).
Few studies were designed to address the issue of possible transmission routes among the population of china.
Six studies had information on possible blood transmission. Two blood transfusion studies and 4 studies of IVDUs
included 837 persons who reported having been exposed
to blood contact i.e., needle sharing and 1,397 who were
never exposed (online Technical Appendix Figure, panel
D). Substantial heterogeneity (I2 87%, p<0.001, by test for
heterogeneity) was detected among those studies; therefore, a random-effects model was used to estimate the OR.
No publication bias was detected (Begg test p = 0.707; Egger test p = 0.363). OR showed a marginal association of
HHV-8 prevalence with blood transfusion (OR 2.01, 95%
CI 0.89–4.56) for possible blood transmission.
Conclusions
This systematic review indicated that HHV-8 prevalence in China varies in different regions. Pooling of data
from 26 studies provided us with a large sample size, which
is one of the strengths of the study. Also, we included studies that were published in the Chinese language and were
not accessible to the international community. The results
of this meta-analysis show that HHV-8 prevalence was
higher in the Xinjiang Uygur Autonomous Region than
other areas in general and among high-risk populations.
Historically, Xinjiang Uygur Autonomous Region has been
regarded as an area in which Kaposi sarcoma is endemic
(13). Notably, geographic variations of HHV-8 infection
within China are not well known and need to be investigated as well.
It has been well documented that HHV-8 prevalence
is higher among HIV-infected persons (14,15). In mainland China, we found a 3-fold increase in HHV-8 infection
among persons with HIV compared with HIV-noninfected
persons. Given the rapid increase of HIV/AIDS cases in
China, HHV-8 could become a severe public health issue
in the future.
According to data from the Xinjiang Uygur Autonomous Region, minority groups were at higher risk for HHV8 infection than the Han ethnic group. Although there was

Figure. Regional distribution of pooled human herpesvirus
8 (HHV-8) prevalence in A) the general population and B)
immunocompromised patients, China.

evidence for considerable heterogeneity among the studies,
the association between ethnicity and HHV-8 risk showed
that minorities were at higher risk for HHV-8 infection
when compared with the Han ethnic group. The reasons
behind this association are not well elucidated. Because all
of the comparisons of HHV-8 difference between minority groups and the Han ethnic group are from the Xinjiang
Uygur Autonomous Region, epidemiologic confirmation
of this observation would require data from other regions,
which is currently unavailable. Our analysis showed a marginally significant association between blood contact and
HHV-8 infection; heterogeneity among studies was substantial. These data indicate that blood-borne transmission
could occur among the Chinese population, a finding that is
consistent with previous reports from other countries (11).
This study has some limitations. The studies included
in this meta-analysis were not evenly distributed throughout China because information was not available from all
the regions. Also, all of the studies might have used different methods for HHV-8 detection because of the lack
of a standard assay; prevalence estimates may have been
underestimated.
In summary, this meta-analysis clearly shows that
the distribution of HHV-8 seroprevalence varies in China.
The available information is still too limited to fully understand HHV-8 prevalence and the risk factors associated
with transmission. Further studies are urgently needed to
explore the epidemiology of HHV-8 infection in different
subpopulations in China.
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